Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase NA 8Phase 3 8Phase 1/2 5Phase 2/3 4Phase 1 4Phase EARLY_PHASE1 1

Status

Recruiting 5Terminated 2Withdrawn 1Unknown 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Other solid neoplasm 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Esophageal Squamous Cell Carcinoma 1Advanced Solid Tumor 1

Interventions

pembrolizumab 109Cyclophosphamide 85fludarabine 67Carboplatin 59Injections 58Bevacizumab 52Specimen Handling 42Gemcitabine 41Paclitaxel 40Magnetic Resonance Spectroscopy 40venetoclax 38Nivolumab 38Cisplatin 37Dexamethasone 35Biopsy 34Temozolomide 31Docetaxel 29atezolizumab 27Oxaliplatin 26Capecitabine 26Pemetrexed 25Fluorouracil 25toripalimab 24abemaciclib 24Irinotecan 24Azacitidine 24Fulvestrant 23Rituximab 21fludarabine phosphate 20durvalumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Recruiting × Immunotherapy × Clear all
NCT07595172 2026-05-19

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

West China Hospital

Phase 1/2 Recruiting
55 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07010120 2025-06-13

A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

West China Hospital

Phase 1/2 Recruiting
29 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06173219 2025-02-27

Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

China-Japan Friendship Hospital

Phase 1/2 Recruiting
38 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06527898 2024-09-19

Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer

Anhui Provincial Hospital

Phase 1/2 Recruiting
45 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06173986 2023-12-18

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Shanghai Chest Hospital

Phase 1/2 Recruiting
50 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡